Skip to content

Press Releases

Filter Releases
 
Press Releases
Date Title and Summary View
Mar 14, 2012
ROCKVILLE, Md., March 14, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced fourth quarter and year-end financial results for the three and twelve month periods ended December 31, 2011. For the full year ended December 31, 2011, the Company's net loss was $4.5 million, or $0.11 per share, compared to a ne...
Apr 23, 2012
Z:M Navigator-April23, 2012-M Navigator: Deal pipeline - 23 April ©2012 M2 COMMUNICATIONS http://www.m2.comThe following is a list of deals covered in detail by M Navigator this week:- SUFF SIGNS LOI FOR CONTROL OF MOBILE APPS DEVELOPERUS-based Suff Holdings (PINK:SUFF),...
Apr 23, 2012
ROCKVILLE, Md., April 23, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced plans to merge with Biota Holdings Limited (ASX:BTA), a Melbourne, Australia company. The execution of the merger implementation agreement will form a combined company to be named Biota Pharmaceuticals, Inc. Biota Pharmaceuticals will be list...
Apr 23, 2012
http://media.marketwire.com/attachments/201010/653964_BIOTA_logo.jpg...
Apr 24, 2012
Z:M Navigator-April24, 2012-Deal snapshot: AUSTRALIAN BIOTA TO MOVE TO US VIA COMBINATION WITH NABI ©2012 M2 COMMUNICATIONS http://www.m2.comAustralian influenza antivirals developer Biota Holdings Ltd (ASX:BTA) will take over US vaccines maker Nabi Biopharmaceuticals (NASDAQ:NABI) in a reverse...
May 3, 2012
ROCKVILLE, Md., May 3, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that it will report its first quarter 2012 financial results on Thursday, May 10, 2012, after the market close. The company will host a live webcast and conference call at 4:30 p.m. EDT that day to discuss these results. The webcast ...
May 10, 2012
ROCKVILLE, Md., May 10, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced its first quarter financial results for the three-month period ended March 31, 2011. The Company reported a net loss of $0.4 million, or $0.01 per share, compared to net income of $2.0 million, or $0.05 per share, for the prior year period....
Jul 2, 2012
ROCKVILLE, Md., July 2, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) (the "Company") today announced that it is commencing a "modified Dutch auction" tender offer for up to $23,000,000 of its common stock at a price per share not less than $1.58 and not greater than $1.72. The tender offer will expire at 12:00 midnight, at ...
Jul 19, 2012
ROCKVILLE, Md., July 19, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) (the "Company") announced today, in connection with its previously announced tender offer (for up to $23 million in value of its common stock at a price per share not less than $1.58 and not greater than $1.72), that it is waiving the following condition ...
Jul 31, 2012
ROCKVILLE, Md., July 31, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) (the "Company") today announced the preliminary results of its "modified Dutch auction" tender offer, which expired at 12:00 midnight, at the end of the day, New York City time, on Monday, July 30, 2012. Based upon preliminary results, the Company expects...
Aug 2, 2012
ROCKVILLE, Md., Aug. 2, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) (the "Company") today announced the final results of its "modified Dutch auction" tender offer, which expired at 12:00 midnight, at the end of the day, New York City time, on Monday, July 30, 2012. In accordance with the terms and conditions of the tender ...
Aug 2, 2012
ROCKVILLE, Md., Aug. 2, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that it will report its second quarter 2012 financial results on Thursday, August 9, after the market close. The company will host a live webcast and conference call at 4:30 p.m. EDT that day to discuss these results. The webcast ca...
Aug 9, 2012
ROCKVILLE, Md., Aug. 9, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced its second quarter financial results for the three-month period ended June 30, 2012. The Company reported a net loss of $2.7 million, or $0.06 per share, compared to net loss of $4.6 million, or $0.11 per share, for the prior year period. ...
Aug 23, 2012
Z:M Navigator-August23, 2012-M Navigator: Deal pipeline - 23 August ©2012 M2 COMMUNICATIONS http://www.m2.comThe following is a list of deals covered in detail by M Navigator this week:- MORGAN STANLEY INFRASTRUCTURE ARM TO BUY OUT SOUTHERN STARMorgan Stanley Infrastruct...
Aug 23, 2012
ROCKVILLE, Md., Aug. 23, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today that it is sending a letter to its stockholders, a copy of which is included below. The letter is in response to the statements made by Mangrove Partners Fund, L.P. and urges Nabi's stockholders to vote their WHITE proxy card accompanying Nabi...
Page:
...
Next Last
 
= add release to Briefcase

Log In

Create an account